Plain-English translation of NCT04933851 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether a short therapy program called ACT1VATE can help adults with type 1 diabetes feel less stressed about their condition and achieve better blood sugar control. The program uses a type of therapy called Acceptance and Commitment Therapy, which teaches practical skills for managing the emotional burden of living with diabetes. You would either receive this new therapy program or standard diabetes education, and researchers would track your blood sugar levels and well-being over 12 months.
Many people with type 1 diabetes experience significant emotional stress about managing their condition, and this stress can make blood sugar control harder. This trial exists to see whether addressing this emotional burden directly—rather than just teaching diabetes management skills—can help improve both mental health and blood sugar outcomes.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll be randomly assigned to one of two groups. One group receives standard one-on-one diabetes education via video calls from a diabetes educator. The other group participates in five group therapy sessions delivered via video by a mental health provider trained in the ACT1VATE program. Throughout the study, you'll have regular check-ins with your diabetes care team, take routine blood sugar tests, and complete online surveys about your well-being at the start, 6 months, and 12 months. The study lasts one year total.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States